Edward Patz
Company: Grid Therapeutics
Job title: Chief Executive Officer
Seminars:
Antibodies, Complement, and Anti-Tumour Immunity 8:30 am
Increasing evidence implicates compliment activities in oncology Targeting complement factor H Conceptualizing drug development targeting angiogenesis in oncologyRead more
day: Conference Day Two
Panel: The Past, Present & Future of Complement in Oncology 9:30 am
Where to target for oncology indications? Discussing complement dependent mechanisms in angiogenesis How can newly discovered complement functions be targeted for therapy?Read more
day: Conference Day Two